CRC
BLUE

Curi RMB Capital’s bluebird bio BLUE Stock Holding History

Curi RMB Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-903
Closed -$224K – 455
2021
Q3 		$224K Sell
903
-629
-41% -$180K 0.01% 428
2021
Q2 		$635K Hold
1,532
– – 0.02% 332
2021
Q1 		$598K Buy
1,532
+2
+0.1% +$985 0.02% 331
2020
Q4 		$858K Buy
1,530
+47
+3% +$29.8K 0.03% 339
2020
Q3 		$1.04M Buy
1,483
+54
+4% +$42.1K 0.04% 296
2020
Q2 		$1.13M Buy
1,429
+151
+12% +$114K 0.05% 289
2020
Q1 		$761K Buy
1,278
+172
+16% +$168K 0.04% 326
2019
Q4 		$1.26M Sell
1,106
-23
-2% -$25K 0.03% 335
2019
Q3 		$1.34M Buy
1,129
+7
+0.6% +$10.7K 0.04% 356
2019
Q2 		$1.85M Sell
1,122
-36
-3% -$62.3K 0.05% 317
2019
Q1 		$2.36M Hold
1,158
– – 0.06% 310
2018
Q4 		$1.49M Sell
1,158
-40
-3% -$61.4K 0.04% 418
2018
Q3 		$2.27M Buy
1,198
+153
+15% +$316K 0.05% 356
2018
Q2 		$2.13M Sell
1,045
-444
-30% -$1.01M 0.05% 366
2018
Q1 		$3.29M Buy
1,489
+537
+56% +$1.37M 0.08% 303
2017
Q4 		$2.2M Sell
952
-522
-35% -$1.06M 0.06% 361
2017
Q3 		$2.62M Buy
+1,474
New +$2.06M 0.07% 334

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Curi RMB Capital's BLUE Position: Q4 2021 in Review

Curi RMB Capital sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 903 shares — an estimated $224K sold.

Curi RMB Capital first reported a position in BLUE in Q3 2017 and held it in 17 quarters. The position peaked at $3.29M in Q1 2018. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • Curi RMB Capital reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • Curi RMB Capital sold 903 bluebird bio shares in Q4 2021, an estimated $224K.
  • Curi RMB Capital first reported a position in bluebird bio in Q3 2017 and held it in 17 quarters.
  • Curi RMB Capital's bluebird bio position peaked at $3.29M in Q1 2018.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on Curi RMB Capital's 13F filing for Q4 2021, filed 26 Jan 2022.